Non-invasive Intracranial Pressure Monitoring Devices Market Size, Share, & Trends Analysis Report By Type (MRI/CT, TMD), By Application (Traumatic Brain Injury, Meningitis), By Region, And Segment Forecasts, 2025 - 2030

Market Size & Trends

The global non-invasive intracranial pressure monitoring devices market size was valued at USD 350.9 million in 2024 and is projected to grow at a CAGR of 5.2% from 2025 to 2030. The growing incidence of neurological disorders and increasing road accidents, which result in traumatic brain injuries, are among the key factors fueling the market growth. In addition, the launch of new technologies, growing demand for minimally invasive surgeries, and the high demand for these devices in trauma care are some other factors contributing to the market growth. The escalating cases of neurological disorders, such as intracranial tumors, hydrocephalus, aneurysms, brain infection, and meningitis, as well as the increasing incidence of trauma events due to road accidents, falls, and sports injuries, are anticipated to fuel market growth.

A major study published in The Lancet Neurology in 2021 revealed that over 3 billion people worldwide were living with a neurological condition, according to data from the World Health Organization (WHO) and the Global Burden of Disease Study. Neurological disorders have become the leading cause of ill health and disability globally, with Disability-adjusted Life Years (DALYs) rising by 18% since 1990. This growing prevalence of neurological conditions drives the demand for the non-invasive intracranial pressure monitoring devices industry to help manage and monitor these conditions more effectively.

According to the American Association for the Surgery of Trauma, road accidents caused approximately 1.2 million deaths globally in 2017, resulting in elevated Intracranial Pressure (ICP) and driving the demand for ICP monitoring devices. In addition, brain infections such as meningitis, which infect the cerebrospinal fluid and increase ICP, further contribute to the market growth. The WHO reported around 30,000 meningitis cases annually in sub-Saharan Africa. ICP monitoring devices are essential for continuous pressure monitoring, enabling early disease recognition and timely treatment by neurosurgeons, thereby boosting the demand for these devices.

It is estimated that 1 in 161 individuals born today will develop brain or nervous system cancer during their lifetime. Annually, around 308,000 people are diagnosed with brain and nervous system cancer globally, resulting in over 251,000 deaths. The increasing prevalence of these conditions drives the demand for advanced diagnostic tools. Moreover, MRI/CT scans are the widely preferred imaging devices owing to their higher sensitivity in assessing elevated ICP in patients with traumatic brain injuries.

Countries such as the U.S. and Canada have witnessed a high prevalence rate of neurological disorders and trauma cases. For instance, according to the report published by the American Association for the Surgery of Trauma in 2020, trauma is one of the leading causes of death in the U.S. for individuals aged up to 45. In addition, the presence of technologically advanced healthcare infrastructure and increasing patient awareness regarding the benefits associated with minimally invasive surgeries are among the major factors contributing to market growth. Furthermore, a rise in the number of road accidents is anticipated to boost the demand for intracranial pressure monitoring devices. For instance, according to the report by the Brain Injury Association of Waterloo-Wellington (BIAWW), over 11,000 individuals die due to brain-related injuries in Canada every year and more than 6,000 become permanently disabled post injuries. This is anticipated to boost market growth over the forecast period.

Furthermore, the global geriatric population is increasing at a high rate. According to the UN Department of Economic and Social Affairs, currently, the global population is 7.7 billion, which is expected to increase to 9.7 billion by 2050. The geriatric population is prone to various neurological conditions as well as traumatic brain injuries. Thus, the increasing geriatric population worldwide is expected to be a high-impact driver for the market during the forecast period. Moreover, the high geriatric population in Asian countries, such as Japan and China, presents several untapped opportunities, thereby boosting the market growth during the forecast period. As per estimates, more than 20% of the population in Japan is over the age of 65 years. According to a report by the WHO, fall-related injuries in the elderly are a major health and social concern in China, with approximately 18% to 44% of elderly people reporting falls.

Type Insights

The MRI/CT segment dominated the non-invasive intracranial pressure monitoring device industry, accounting for the largest revenue share of 28.4% in 2024. These devices help to get results faster and safely, and they are easy to use and provide excellent images with high contrast between pathologic and normal tissues. Moreover, MRI/CT scans are the widely preferred imaging devices owing to their higher sensitivity to assess patients with traumatic brain injuries with elevated ICPs. Thus, increasing applications in the diagnosis and staging of neurological diseases, as well as their advantages over other imaging modalities, have fueled the growth of this segment.

The optic nerve sheath diameter segment is expected to grow at the fastest CAGR of 5.7% over the forecast period. It is the most appropriate and widely preferred modality for emergency medical situations, such as severe head trauma, hydrocephalus, and intracranial hemorrhage. The increasing prevalence of elevated ICP from neurological and systemic disorders is driving the demand for non-invasive ICP monitoring. Early detection is vital for improved outcomes. Ultrasound measurement of Optic Nerve Sheath Diameter (US-ONSD) provides a fast, safe, and non-invasive method for real-time ICP assessment, correlating with papilledema.

Application Insights

The traumatic brain injury segment dominated the non-invasive intracranial pressure monitoring devices industry with the largest revenue share in 2024. Traumatic Brain Injury (TBI) affects over 54 to 60 million people annually, often resulting in hospitalization or death. TBI is among the leading causes of mortality and permanent disability. The Global Burden of Disease Study 2016 reported 27.08 million new TBI cases, with falls being the primary cause. Road Traffic Accidents (RTAs), violence, sports injuries, and work-related accidents also contribute to TBI. This high incidence of TBI, which requires effective monitoring and early intervention, drives the demand for non-invasive intracranial pressure monitoring devices for safer, real-time management of patients.

The intracerebral hemorrhage segment in the non-invasive intracranial pressure monitoring device industry is expected to grow at a significant CAGR over the forecast period. Intracerebral Hemorrhage (ICH) remains a major global health issue, contributing significantly to mortality and disability. The GBD 2021 study identified stroke as the third-leading cause of death, responsible for 7.3 million deaths (10.7% of all deaths), and the fourth-leading cause of DALYs, accounting for 160.5 million DALYs (5.6% of total DALYs). ICH represents 28.8% of all stroke incidents, making it a substantial part of the overall stroke burden. This high prevalence and the critical nature of ICH cases drive the demand for non-invasive intracranial pressure monitoring devices to effectively manage and monitor patients at risk of elevated ICP.

The other segment, which includes brain edema, hydrocephalus, and CNS infection, is expected to grow rapidly in the coming years. Brain edema results in elevated intracranial pressure, which involves precise measurement for early and effective treatment. Therefore, a major portion of the global population is suffering from CNS infection, hydrocephalus, or brain edema, which depends on ICP measurement for timely and safe treatment of such conditions.

Regional Insights

The North America non-invasive intracranial pressure monitoring device market dominated the global market and accounted for the largest revenue share of 45.1% in 2024. Each year, 2 million Americans are treated for TBI, with 56,000 deaths and 80,000 individuals requiring assistance due to TBI-related impairments. In addition, 5.3 million Americans live with TBI-related disabilities, costing over USD 56 billion annually in care and lost earnings. This high prevalence and the critical need for effective management of TBI complications, including elevated ICP, drive the demand for non-invasive intracranial pressure monitoring devices industry in North America.

The non-invasive intracranial pressure monitoring market in the U.S. led the North America market with the largest revenue share in 2024. In 2023, approximately 25,000 individuals in the U.S. were diagnosed with brain and nervous system cancers, with approximately 19,000 deaths. These cancers represent 1 in every 100 cancer diagnoses in the U.S. and are among the most common cancers in children and young adults.

Europe Non-Invasive Intracranial Pressure Monitoring Device Market Trends

The Europe non-invasive intracranial pressure monitoring device market held a substantial market share in 2024. In the European Union, brain injuries result in 1.5 million hospital admissions annually and 57,000 deaths. The incidence rate is 287 per 100,000 people, with a fatality rate of 15 per 100,000. Some countries, such as the UK, report significantly higher incidence rates, reaching 453 per 100,000, with 10.9% of these cases classified as moderate to severe. Around 165 million people in Europe are currently affected by brain disorders, and it is projected that 1 in 3 individuals will face a neurological or mental health condition at some stage in their life.

Asia Pacific Non-Invasive Intracranial Pressure Monitoring Device Market Trends

The Asia Pacific non-invasive intracranial pressure monitoring device market is expected to grow at the fastest CAGR of 6.2% over the forecast period. This is attributed to the presence of a large patient base in the emerging economies, such as India and China, along with rising healthcare expenditures in this region. Moreover, an increase in the number of clinical trials and high R&D investments by global market players, owing to low-cost services in the region, are high-impact drivers in the market. In addition, the increasing incidence of road accidents and neurological diseases is aiding the market growth in this region.

The non-invasive intracranial pressure monitoring device market in China dominated the Asia Pacific market with the largest revenue share in 2024. In China, TBI is a leading cause of injury and the fifth-leading cause of death among younger adults, with RTAs contributing to 61% of TBIs. In addition, the country has a growing elderly population with cognitive impairments, including 15.07 million individuals over 60 with dementia and 38.8 million with Mild Cognitive Impairment (MCI).

Key Non-invasive Intracranial Pressure Monitoring Devices Company Insights

Key companies in the global non-invasive intracranial pressure monitoring device industry include Medtronic, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, and RAUMEDIC AG, among others. These companies focus on innovation, strategic partnerships, and geographic expansion. They invest in R&D to improve device accuracy and usability, ensure compliance with regulatory standards, and offer affordable solutions. Clinical studies and training programs help increase adoption and expand into emerging markets, which drives growth and market share.

• Medtronic operates in over 150 countries and offers a wide range of products across various medical fields, including cardiovascular, diabetes, neurological, and surgical solutions. Medtronic is known for its innovations and focuses on developing advanced medical devices, therapies, and services that address critical healthcare needs.

• Integra LifeSciences Corporation is a medical technology company that develops, manufactures, and markets innovative solutions for patients and healthcare providers. It is headquartered in Princeton, New Jersey, and focuses on a wide range of medical areas, including neurosurgery, orthopedics, and wound care products. The company is known for its expertise in regenerative medicine and advanced surgical technologies.

Recent Developments

• In February 2025, Children’s National Hospital partnered with a Swiss medical device company, Compremium AG, to co-develop non-invasive pressure monitoring technologies for pediatric patients. The collaboration focuses on diagnosing pressure-related conditions such as intracranial pressure and venous pressure, particularly in patients with congenital heart disease.

• In July 2024, SanBio Co., Ltd. received conditional marketing approval in Japan for “AKUUGO suspension for intracranial implantation,” a groundbreaking treatment for chronic motor paralysis caused by Traumatic Brain Injury (TBI).

Non-invasive Intracranial Pressure Monitoring Devices Market Report Scope

Global Non-invasive Intracranial Pressure Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global non-invasive intracranial pressure monitoring devices market report based on type, application, and region:

• Type Outlook (Revenue, USD Million; 2018 - 2030)

  • Transcranial Doppler Ultrasonography 

  • Tympanic Membrane Displacement (TMD)

  • Optic Nerve Sheath Diameter

  • MRI/CT

  • Fundoscopy (papilledema)

• Application Outlook (Revenue, USD Million; 2018 - 2030)

  • Traumatic Brain Injury

  • Intracerebral Hemorrhage

  • Meningitis

  • Subarachnoid Hemorrhage

  • Others

• Regional Outlook (Revenue, USD Million; 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait